Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
6,308,290
-
Share change
-
+508,916
-
Total reported value
-
$49,689,460
-
Price per share
-
$7.88
-
Number of holders
-
36
-
Value change
-
+$4,018,404
-
Number of buys
-
19
-
Number of sells
-
12
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2016
As of 30 Sep 2016,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,308,290 shares.
The largest 10 holders included
FMR LLC, JPMORGAN CHASE & CO, STIFEL FINANCIAL CORP, Lombard Odier Asset Management (USA) Corp, BlackRock Fund Advisors, VANGUARD GROUP INC, STATE STREET CORP, Allianz Asset Management GmbH, NORTHERN TRUST CORP, and BlackRock Institutional Trust Company, N.A..
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.